2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Time Trends in the Diagnosis of Colorectal Cancer With Obstruction, Perforation, and Emergency Admission After the Introduction of Population-Based Organized Screening

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          What is the association of organized, population-based colorectal cancer screening with the rate of obstructions, perforations, and emergency admissions prior to a colorectal cancer diagnosis?

          Findings

          This cohort study of 1861 Canadian adults with a diagnosis of colorectal cancer found no change in the rate of obstructions and perforations, but found a significant decrease in the rate of emergency hospital admissions after the implementation of organized colorectal cancer screening. Individuals who were up to date for colorectal screening were less likely to receive a diagnosis of an obstruction or perforation or have an emergency admission.

          Meaning

          Targeted colorectal cancer screening strategies are needed that focus on individuals at higher risk of an emergency presentation.

          Abstract

          Importance

          Up to 30% of patients with a diagnosis of colorectal cancer (CRC) present as an emergency (an intestinal obstruction, perforation, or emergency hospital admission) (OPE). There are limited data about the association of organized, population-based colorectal cancer screening with the rate of emergency presentations.

          Objective

          To examine the association of CRC screening with OPE at cancer diagnosis and time trends in the rate of OPE after the start of organized CRC screening using a highly sensitive fecal occult blood test.

          Design, Setting, and Participants

          A historical cohort study was conducted among 1861 individuals 52 to 74 years of age with a diagnosis of CRC from January 1, 2007, to December 31, 2015, who lived in Winnipeg, Manitoba, a province with universal health care and an organized CRC screening program. Statistical analysis was performed from January 22, 2019, to February 26, 2020.

          Exposures

          Variables included prior CRC screening, era of diagnosis, cancer stage at diagnosis, tumor site in the colon, area level mean household income, primary care continuity of care, and comorbidity.

          Main Outcomes and Measures

          The primary outcomes were defined as an OPE. Logistic regression was used to evaluate factors associated with OPE at CRC diagnosis. Trends over time were calculated using Joinpoint Regression.

          Results

          From 2007 to 2015, 1861 individuals 52 to 74 years of age (1133 men; median age, 65.1 years [interquartile range, 60.0-70.3 years]) received a diagnosis of CRC in Winnipeg. Most individuals had good continuity of care and moderate comorbidities. Overall, 345 individuals (18.5%) had an OPE. The rate of emergency hospital admissions decreased significantly from 2007 (the start of the organized, province-wide CRC screening program) to 2015 (annual change, –7.1%; 95% CI, –11.3% to –2.8%; P = .01). There was no change in the rate of obstructions or perforations or stage IV CRCs. Individuals who were up to date for CRC screening were significantly less likely to receive a diagnosis of an OPE (odds ratio, 0.38; 95% CI, 0.28-0.50; P < .001). The results were similar after adding emergency department visits and stage IV CRC at diagnosis to the outcome.

          Conclusions and Relevance

          This study suggests that the rate of emergency hospital admissions decreased over time for individuals who underwent CRC screening, but there was no change in the rate of obstructions and perforations. Individuals who were up to date for CRC screening were less likely to have a CRC diagnosis with an OPE.

          Abstract

          This cohort study examines the association of colorectal cancer screening with an intestinal obstruction, perforation, or emergency hospital admission at diagnosis, as well as trends in the rate of these outcomes after the start of colorectal cancer screening using a highly sensitive fecal occult blood test.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          Worldwide variations in colorectal cancer.

          Previous studies have documented significant international variations in colorectal cancer rates. However, these studies were limited because they were based on old data or examined only incidence or mortality data. In this article, the colorectal cancer burden and patterns worldwide are described using the most recently updated cancer incidence and mortality data available from the International Agency for Research on Cancer (IARC). The authors provide 5-year (1998-2002), age-standardized colorectal cancer incidence rates for select cancer registries in IARC's Cancer Incidence in Five Continents, and trends in age-standardized death rates by single calendar year for select countries in the World Health Organization mortality database. In addition, available information regarding worldwide colorectal cancer screening initiatives are presented. The highest colorectal cancer incidence rates in 1998-2002 were observed in registries from North America, Oceania, and Europe, including Eastern European countries. These high rates are most likely the result of increases in risk factors associated with "Westernization," such as obesity and physical inactivity. In contrast, the lowest colorectal cancer incidence rates were observed from registries in Asia, Africa, and South America. Colorectal cancer mortality rates have declined in many longstanding as well as newly economically developed countries; however, they continue to increase in some low-resource countries of South America and Eastern Europe. Various screening options for colorectal cancer are available and further international consideration of targeted screening programs and/or recommendations could help alleviate the burden of colorectal cancer worldwide.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study.

            Colonoscopy is used for early detection and prevention of colorectal cancer, but evidence on the magnitude of overall protection and protection according to anatomical site through colonoscopy performed in the community setting is sparse. We assessed whether receiving a colonoscopy in the preceding 10-year period, compared with no colonoscopy, was associated with prevalence of advanced colorectal neoplasms (defined as cancers or advanced adenomas) at various anatomical sites. A statewide cross-sectional study was conducted among 3287 participants in screening colonoscopy between May 1, 2005, and December 31, 2007, from the state of Saarland in Germany who were aged 55 years or older. Prevalence of advanced colorectal neoplasms was ascertained by screening colonoscopy and histopathologic examination of any polyps excised. Previous colonoscopy history was obtained by standardized questionnaire, and its association with prevalence of advanced colorectal neoplasms was estimated, after adjustment for potential confounding factors by log-binomial regression. Advanced colorectal neoplasms were detected in 308 (11.4%) of the 2701 participants with no previous colonoscopy compared with 36 (6.1%) of the 586 participants who had undergone colonoscopy within the preceding 10 years. After adjustment, overall and site-specific adjusted prevalence ratios for previous colonoscopy in the previous 10-year period were as follows: overall, 0.52 (95% confidence interval [CI] = 0.37 to 0.73); cecum and ascending colon, 0.99 (95% CI = 0.50 to 1.97); hepatic flexure and transverse colon, 1.21 (95% CI = 0.60 to 2.42); right-sided colon combined (cecum to transverse colon), 1.05 (95% CI = 0.63 to 1.76); splenic flexure and descending colon, 0.36 (95% CI = 0.16 to 0.82); sigmoid colon, 0.29 (95% CI = 0.16 to 0.53); rectum, 0.07 (95% CI = 0.02 to 0.40); left colon and rectum combined (splenic flexure to rectum, referred to as left-sided elsewhere), 0.33 (95% CI = 0.21 to 0.53). Prevalence of left-sided advanced colorectal neoplasms, but not right-sided advanced neoplasms, was strongly reduced within a 10-year period after colonoscopy, even in the community setting.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Recommendations on screening for colorectal cancer in primary care.

                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                26 May 2020
                May 2020
                26 May 2020
                : 3
                : 5
                : e205741
                Affiliations
                [1 ]Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba
                [2 ]Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba
                [3 ]Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, Manitoba
                [4 ]Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba
                [5 ]Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Phoenix, Arizona
                [6 ]Department of Medicine, University of Utah, Salt Lake City
                [7 ]Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba
                Author notes
                Article Information
                Accepted for Publication: February 27, 2020.
                Published: May 26, 2020. doi:10.1001/jamanetworkopen.2020.5741
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Decker KM et al. JAMA Network Open.
                Corresponding Author: Kathleen M. Decker, PhD, Research Institute in Oncology and Hematology, CancerCare Manitoba, 675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada ( kdecker@ 123456cancercare.mb.ca ).
                Author Contributions: Drs Decker and Singh had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Decker, Samadder, Singh.
                Acquisition, analysis, or interpretation of data: Decker, Lambert, Nugent, Biswanger, Singh.
                Drafting of the manuscript: Decker, Samadder.
                Critical revision of the manuscript for important intellectual content: All authors.
                Statistical analysis: Decker, Lambert, Nugent.
                Obtained funding: Decker, Singh.
                Administrative, technical, or material support: Biswanger, Singh.
                Supervision: Decker, Samadder, Singh.
                Conflict of Interest Disclosures: Drs Decker and Singh reported receiving grants from CancerCare Manitoba Foundation during the conduct of the study. Dr Singh reported serving on the advisory board of Takeda Canada, Pendopharm, Ferring Merck Canada, and Guardant Health Inc; and receiving an educational grant from Ferring and research funding (investigator-initiated study) from Merck Canada. No other disclosures were reported.
                Additional Contributions: We gratefully acknowledge the CancerCare Manitoba Foundation for supporting this research and Manitoba Health for the provision of data.
                Article
                zoi200269
                10.1001/jamanetworkopen.2020.5741
                7251446
                32453385
                b4db3123-415c-4741-b1d2-c309811ddb86
                Copyright 2020 Decker KM et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 25 November 2019
                : 27 February 2020
                Categories
                Research
                Original Investigation
                Online Only
                Public Health

                Comments

                Comment on this article